Nuclear Medicine/Radiopharmaceuticals Market to depict appreciable growth prospects over 2028 | General Electric Co. (healthcare division), Medtronic, Inc., Bayer AG, Cardinal Health, Inc., Mallinckrodt plc.
The Nuclear Medicine/Radiopharmaceuticals Market report highlights market opportunities and competitive scenarios for Nuclear Medicine/Radiopharmaceuticals on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the Nuclear Medicine/Radiopharmaceuticals market.
Get Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-61865#utm_source=SCI&utm_medium=SG
The Nuclear Medicine/Radiopharmaceuticals market report highlights market opportunities and competitive scenarios for Nuclear Medicine/Radiopharmaceuticals on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the Nuclear Medicine/Radiopharmaceuticals market.
Growth in the nuclear medicine market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
Objectives of this report:
o To estimate the market size for the nuclear medicine/radiopharmaceuticals market on a regional and global basis.
o To identify major segments in the nuclear medicine/radiopharmaceuticals market and evaluate their market shares and demand.
o To provide a competitive scenario for the nuclear medicine/radiopharmaceuticals market with major developments observed by key companies in the historic years.
o To evaluate key factors governing the dynamics of the nuclear medicine/radiopharmaceuticals market and their potential gravity during the forecast period.
Make an Inquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-61865#utm_source=SCI&utm_medium=SG
The global nuclear medicine market has been categorized on the basis of four major regional segments–North America, Europe, the Asia Pacific, and the Rest of the World. North America accounted for the largest share of the nuclear medicine market. The large share can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the region.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
Mallinckrodt plc., General Electric Co. (healthcare division), Medtronic, Inc., Bayer AG, Cardinal Health, Inc., Lantheus Medical Imaging, Inc., and IBA Group
Market Segmentation:
By Type:
o Diagnostic
o Therapeutic
By Modality:
o SPECT
o PET
o Alpha-Emitters
o Beta-Emitters
o Brachytherapy
By Application:
o Oncology
o Cardiology
o Neurology
o Thyroid
By Procedures:
o Central Nervous System
o Endocrine,
o Skeletal
o Gastrointestinal
o Genito-Urinary
o Pulmonary
By End User:
o Hospitals and Diagnostic Centers
o Research Institutes
By Region:
North America
o North America, by Country
US
Canada
Mexico
o North America, by Type
o North America, by Modality
o North America, by Application
o North America, by Procedures
o North America, by End User
Western Europe
o Western Europe, by Country
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Western Europe
o Western Europe, by Type
o Western Europe, by Modality
o Western Europe, by Application
o Western Europe, by Procedures
o Western Europe, by End User
Asia Pacific
o Asia Pacific, by Country
China
India
Japan
South Korea
Australia
Indonesia
Rest of Asia Pacific
o Asia Pacific, by Type
o Asia Pacific, by Modality
o Asia Pacific, by Application
o Asia Pacific, by Procedures
o Asia Pacific, by End User
Eastern Europe
o Eastern Europe, by Country
Russia
Turkey
Rest of Eastern Europe
o Eastern Europe, by Type
o Eastern Europe, by Modality
o Eastern Europe, by Application
o Eastern Europe, by Procedures
o Eastern Europe, by End User
Middle East
o Middle East, by Country
UAE
Saudi Arabia
Qatar
Iran
Rest of Middle East
o Middle East, by Type
o Middle East, by Modality
o Middle East, by Application
o Middle East, by Procedures
o Middle East, by End User
Rest of the World
o Rest of the World, by Country
South America
Africa
o Rest of the World, by Type
o Rest of the World, by Modality
o Rest of the World, by Application
o Rest of the World, by Procedures
o Rest of the World, by End User
Reasons to Buy This Report:
o Offers unique insights into the decision-making process for every possible segment that aids in strategic decision making.
o Market size estimate of regionally and internationally focused nuclear medicine/radiopharmaceuticals market.
o Unique research methodology based on the dynamics of the nuclear medicine/radiopharmaceuticals market.
o Identification of major companies operating in the industry with key strategies adopted in the recent years
o Exhaustive scope to help each stakeholder across the value chain of nuclear medicine/radiopharmaceuticals market.
Customization:
This study is customized to meet your specific requirements:
o By Segment
o By Sub-segment
o By Region/Country
o Product Specific Competitive Analysis
Contact:
Quince Market Insights
Ajay D. (Knowledge Partner)
Office No- A109
Pune, Maharashtra 411028
Phone: US +1 208 405 2835 UK +44 121 364 6144 APAC +91 706 672 4848
Email: [email protected]
Web: www.quincemarketinsights.com
ABOUT US:
QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.
